Abstract
Coronary artery bypass surgery is considered as the gold standard treatment of unprotected left main coronary artery (ULMCA) disease. Over the last 20 years, improvement in stent technology and operators experience explained the increased number of reports on the results of percutaneous coronary interventions (PCIs) for the treatment of left main (LM) coronary artery lesion. The recent data comparing efficacy and safety of PCIs using drug-eluting stent and coronary artery bypass surgery showed comparable results in terms of safety and a lower need for repeat revascularization for coronary artery bypass surgery. Patient selection for both techniques is fundamental and directly impacts the clinical outcome. Further randomized trials must be conducted to precise the indications of both techniques of revascularization in the treatment of LM disease. Published on behalf of the European Society of Cardiology. All rights reserved.
| Original language | English |
|---|---|
| Pages (from-to) | 36-50 |
| Number of pages | 15 |
| Journal | European Heart Journal |
| Volume | 33 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Jan 2012 |
Fingerprint
Keywords
- Bifurcation lesions
- Coronary bypass grafting
- Left main coronary artery disease
- Percutaneous coronary interventions
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Cite this
Current management of left main coronary artery disease. / Fajadet, Jean; Chieffo, Alaide.
In: European Heart Journal, Vol. 33, No. 1, 01.2012, p. 36-50.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Current management of left main coronary artery disease
AU - Fajadet, Jean
AU - Chieffo, Alaide
PY - 2012/1
Y1 - 2012/1
N2 - Coronary artery bypass surgery is considered as the gold standard treatment of unprotected left main coronary artery (ULMCA) disease. Over the last 20 years, improvement in stent technology and operators experience explained the increased number of reports on the results of percutaneous coronary interventions (PCIs) for the treatment of left main (LM) coronary artery lesion. The recent data comparing efficacy and safety of PCIs using drug-eluting stent and coronary artery bypass surgery showed comparable results in terms of safety and a lower need for repeat revascularization for coronary artery bypass surgery. Patient selection for both techniques is fundamental and directly impacts the clinical outcome. Further randomized trials must be conducted to precise the indications of both techniques of revascularization in the treatment of LM disease. Published on behalf of the European Society of Cardiology. All rights reserved.
AB - Coronary artery bypass surgery is considered as the gold standard treatment of unprotected left main coronary artery (ULMCA) disease. Over the last 20 years, improvement in stent technology and operators experience explained the increased number of reports on the results of percutaneous coronary interventions (PCIs) for the treatment of left main (LM) coronary artery lesion. The recent data comparing efficacy and safety of PCIs using drug-eluting stent and coronary artery bypass surgery showed comparable results in terms of safety and a lower need for repeat revascularization for coronary artery bypass surgery. Patient selection for both techniques is fundamental and directly impacts the clinical outcome. Further randomized trials must be conducted to precise the indications of both techniques of revascularization in the treatment of LM disease. Published on behalf of the European Society of Cardiology. All rights reserved.
KW - Bifurcation lesions
KW - Coronary bypass grafting
KW - Left main coronary artery disease
KW - Percutaneous coronary interventions
UR - http://www.scopus.com/inward/record.url?scp=84855514585&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84855514585&partnerID=8YFLogxK
U2 - 10.1093/eurheartj/ehr426
DO - 10.1093/eurheartj/ehr426
M3 - Article
C2 - 22210689
AN - SCOPUS:84855514585
VL - 33
SP - 36
EP - 50
JO - European Heart Journal
JF - European Heart Journal
SN - 0195-668X
IS - 1
ER -